| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |